These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2983758)

  • 21. Resistance to parathyroid hormone-induced inhibition of inorganic phosphate transport in opossum kidney cells cultured in low inorganic phosphate medium.
    Caverzasio J; Bonjour JP
    J Endocrinol; 1992 Sep; 134(3):361-8. PubMed ID: 1328453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of the in vivo parathyroid hormone-mediated calcemic response in rats by a synthetic hormone antagonist.
    Doppelt SH; Neer RM; Nussbaum SR; Federico P; Potts JT; Rosenblatt M
    Proc Natl Acad Sci U S A; 1986 Oct; 83(19):7557-60. PubMed ID: 3463984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parathyroid hormone stimulates phosphate efflux through an apparently adenosine 3',5'-monophosphate-independent process in rat parotid cell aggregates.
    Shiraki M; Gee MV; Baum BJ; Roth GS
    Endocrinology; 1986 May; 118(5):2009-15. PubMed ID: 2422014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new highly potent parathyroid hormone antagonist: [D-Trp12,Tyr34]bPTH-(7-34)NH2.
    Goldman ME; McKee RL; Caulfield MP; Reagan JE; Levy JJ; Gay CT; DeHaven PA; Rosenblatt M; Chorev M
    Endocrinology; 1988 Nov; 123(5):2597-9. PubMed ID: 2844517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of dexamethasone on parathyroid hormone (PTH) and PTH-related protein regulated phosphate uptake in opossum kidney cells.
    Kaufmann M; Muff R; Fischer JA
    Endocrinology; 1991 Apr; 128(4):1819-24. PubMed ID: 1848502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of an in vitro parathyroid hormone antagonist in vivo in dogs.
    Segre GV; Rosenblatt M; Tully GL; Laugharn J; Reit B; Potts JT
    Endocrinology; 1985 Mar; 116(3):1024-9. PubMed ID: 2982567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estrogen blocks parathyroid hormone (PTH)-stimulated osteoclast-like cell formation by selectively affecting PTH-responsive cyclic adenosine monophosphate pathway.
    Kaji H; Sugimoto T; Kanatani M; Nasu M; Chihara K
    Endocrinology; 1996 Jun; 137(6):2217-24. PubMed ID: 8641168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-function studies of analogues of parathyroid hormone (PTH)-1-34 containing beta-amino acid residues in positions 11-13.
    Peggion E; Mammi S; Schievano E; Silvestri L; Schiebler L; Bisello A; Rosenblatt M; Chorev M
    Biochemistry; 2002 Jun; 41(25):8162-75. PubMed ID: 12069609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of hormone-induced cyclic AMP response to parathyroid hormone and prostaglandin E2 in cells cultured from human giant cell tumors of bone.
    Goldring SR; Dayer JM; Krane SM
    Calcif Tissue Int; 1979; 29(3):193-200. PubMed ID: 93016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The human PTH2 receptor: binding and signal transduction properties of the stably expressed recombinant receptor.
    Behar V; Pines M; Nakamoto C; Greenberg Z; Bisello A; Stueckle SM; Bessalle R; Usdin TB; Chorev M; Rosenblatt M; Suva LJ
    Endocrinology; 1996 Jul; 137(7):2748-57. PubMed ID: 8770894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dissociation of second messenger activation by parathyroid hormone fragments in osteosarcoma cells.
    Fujimori A; Cheng SL; Avioli LV; Civitelli R
    Endocrinology; 1991 Jun; 128(6):3032-9. PubMed ID: 1645259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Formation of parathormone 8-34 by cathepsin-D digestion of parathormone and its efficacy as a hormone antagonist.
    Hamilton JW; MacGregor RR; Jilka RL
    Mol Cell Endocrinol; 1986 Feb; 44(2):179-83. PubMed ID: 3005087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stimulation by defined parathyroid hormone fragments of cell proliferation in skeletal-derived cell cultures.
    Sömjen D; Binderman I; Schlüter KD; Wingender E; Mayer H; Kaye AM
    Biochem J; 1990 Dec; 272(3):781-5. PubMed ID: 2176478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation in vivo of a potent parathyroid hormone antagonist: [Nle8,18,D-Trp12,Tyr34]bPTH(7-34)NH2.
    Dresner-Pollak R; Yang QM; Behar V; Nakamoto C; Chorev M; Rosenblatt M
    J Bone Miner Res; 1996 Aug; 11(8):1061-5. PubMed ID: 8854241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Down-regulation of the receptor for parathyroid hormone (PTH) and PTH-related peptide by PTH in primary fetal rat osteoblasts.
    Jongen JW; Willemstein-van Hove EC; van der Meer JM; Bos MP; Jüppner H; Segre GV; Abou-Samra AB; Feyen JH; Herrmann-Erlee MP
    J Bone Miner Res; 1996 Sep; 11(9):1218-25. PubMed ID: 8864895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of fully active biotinylated analogues of parathyroid hormone and parathyroid hormone-related protein as tools for the characterization of parathyroid hormone receptors.
    Roubini E; Duong LT; Gibbons SW; Leu CT; Caulfield MP; Chorev M; Rosenblatt M
    Biochemistry; 1992 Apr; 31(16):4026-33. PubMed ID: 1314656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human parathyroid hormone (PTH)-related protein and human PTH: comparative biological activities on human bone cells and bone resorption.
    Fukayama S; Bosma TJ; Goad DL; Voelkel EF; Tashjian AH
    Endocrinology; 1988 Dec; 123(6):2841-8. PubMed ID: 2848688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural requirements for parathyroid hormone action in mature bone. Effects on release of cyclic adenosine monophosphate and bone gamma-carboxyglutamic acid-containing protein from perfused rat hindquarters.
    Calvo MS; Fryer MJ; Laakso KJ; Nissenson RA; Price PA; Murray TM; Heath H
    J Clin Invest; 1985 Dec; 76(6):2348-54. PubMed ID: 3001148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inactivation of pertussis toxin-sensitive guanyl nucleotide-binding proteins increase parathyroid hormone receptors and reverse agonist-induced receptor down-regulation in ROS 17/2.8 cells.
    Abou-Samra AB; Jueppner H; Potts JT; Segre GV
    Endocrinology; 1989 Nov; 125(5):2594-9. PubMed ID: 2477233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parathyroid hormone (PTH)-(1-34), [Nle(8,18),Tyr34]PTH-(3-34) amide, PTH-(1-31) amide, and PTH-related peptide-(1-34) stimulate phosphatidylcholine hydrolysis in UMR-106 osteoblastic cells: comparison with effects of phorbol 12,13-dibutyrate.
    Singh AT; Kunnel JG; Strieleman PJ; Stern PH
    Endocrinology; 1999 Jan; 140(1):131-7. PubMed ID: 9886817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.